PepsiCo Inc.'s CEO, Ramon Laguarta, has stated that the rise in weight loss and diabetes medications has had a negligible effect on the company's business. Despite warnings about the potential impact of appetite-suppressing drugs on food consumption habits, Laguarta remains confident in PepsiCo's strategy of offering healthier options and smaller package sizes. The company has reported a nearly 7% rise in net sales to $23.45 billion and has adjusted its full-year forecast upwards for the third consecutive quarter.